Dr. Laurent DECORY

Aurealis Therapeutics is a Swiss-Finnish private synthetic biology company focusing on development of GMO cell & gene therapies. My role is to take Aurealis Therapeutics to the next stage of pre-commercialization by leading Business Development, Health Economics, Marketing & Communication and Scientific Advisory activities. My mission: together with the team, board and advisors, make chronic wounds a thing of the past and tackle multi-target inflammatory diseases with breakthrough cell and gene therapies

Aurealis Therapeutics develops AUP-16, the four-in-one biologic drug for chronic non-healing wounds and regenerative diseases. Chronic wounds represent a major unmet medical need and a significant burden to patients and society. I'm working with the team to bring this game-changing technology into clinical proof-of-concept and commercialization. I also share the passion to expand this clinical grade drug product across a spectrum of regenerative and inflammatory indications

BlueJet Consulting provides Commercialization Consulting for Pharma, Biotech and MedTech: Business Transformation, Resource Allocation, Launch Readiness & Execution, Segmentation & Targeting, Execution Excellence

BSN medical, now part of Essity, is a global leader in wound care & related vascular diseases, lymphology and non-invasive orthopaedics with well-known brands such as Leukoplast, Cutimed, JOBST, Delta Cast and Actimove. My role is to mobilize the organization towards commercial productivity, execution, and launch excellence globally: implement commercial expansion strategy, optimize go-to-market models and ensure transparent execution globally, launch excellence, strategic merger & acquisition, e-Commerce.

Takeda new commercial model definition. Affiliate re-design, capability deployment, CRM enablement, launch excellence in specialty: Oncology, Gastro-Enterology, CNS. Support Region, country and franchise heads in Europe and Canada. Commercial Integration Takeda-Nycomed Europe & Canada Commercial expansion in Emerging Growth Markets

Lead business transformation in Europe, Canada and emerging growth markets (Asia, Middle East): resource optimization, key account management, commercial design, EBIT maximization, product launch and growth (Oncology, Surgey, Respiratory, Rheumatology, Gastro-Enterology), CRM and performance management. Support to area management, commercial integration / M&A. Managed HQ team and global implementation network of Regional champions.

Sales force effectiveness, sales and marketing resource optimization, call effectiveness, first line management transformation program, fact based segmentation and targeting, team coordination with 25 countries, product launch maximization (Oncology, Diabetes, Cardiology, Osteoporosis, CNS)

Segmentation and targeting, profiling, marketing optimization, customer relationship management, multi-channel marketing and sales, product launch support in Oncology, Cardiology, Thrombosis, Diabetes and Anti-Infectives primarily in EU 5.

Multi-channel Marketing and Sales, nurse and patient-support programs, Medical Education and KOL management, collaboration with patient associations. Support global launches in Oncology, Diabetes, Thrombosis. Award-winning ZoomCancer, ZoomDiabète disease management & digital programs including medical education, online communities, e-newsletters, mobile channels... Support to mature portfolio through direct marketing and eCommerce initiatives. Head of Oncology global disease program.

Marketing and Sales, Finance & controlling, Human Resources, Commercial Law, Supply Chain, eCommerce, Change Management

Central & peripheral nervous system, hearing and deafness, impact of antibiotics and noise exposure, electron microscopy, cell culture, acoustics, physical and electrical modelling

Central and peripheral nervous system, pharmacology, physiology, cell biology, patho-physiology, electro-physiology